GLP1R and obesity disorder: Besides the MC4R‐targeted treatment, glucagon‐like peptide‐1 (GLP‐1) receptor agonists (such as semaglutide) in combination with lifestyle interventions can reduce body weight in individuals with overweight or obesity.56